J+D Forecasting

Cheadle Hulme, United Kingdom Founded: 2005 • Age: 21 yrs Acquired By Evaluate
Pharmaceutical forecasting services are provided for global and local markets.

About J+D Forecasting

J+D Forecasting is a Healthcare company based in Cheadle Hulme (United Kingdom) founded in 2005, and was acquired by Evaluate in January 2024. It operates as a pharmaceutical forecasting services are provided for global and local markets. J+D Forecasting offers products and services including FC365, FC+, Custom Model Build, and Forecasting Training. Its focus areas include Biopharma Outsourcing. Its legal entity is J&D Consulting Limited.

Company details

JD Forecasting was founded in 2005 and is based in Cheadle Hulme, United Kingdom. Operations focus on the pharmaceutical sector, where forecasting servicesboth global and localare offered alongside business insights, pharmaceutical training, and software support. These services assist in strategic and operational investment decisions within the industry.

  • Headquarters Cheadle Hulme, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website jdforecasting.com
  • Social LinkedIn X YouTube
  • Acquired by Evaluate (Jan 2024)
  • Legal Name J&D Consulting Limited
Key Metrics

Products & Services of J+D Forecasting

J+D Forecasting offers a comprehensive portfolio of products and services, including FC365, FC+, Custom Model Build, and Forecasting Training.

FC365
Forecasting Platform

Comprehensive platform for data management and strategic forecasting processes.

FC+
Forecasting Software

Software suite for epidemiology, sales, and oncology forecasting models.

Custom Model Build
Custom Solutions

Excel-based models tailored for local and global forecasting needs.

Forecasting Training
Educational Services

Training programs to enhance forecasting skills in pharmaceuticals.

Apps and channels of J+D Forecasting

its YouTube channel JD Forecasting has 7 subscribers and 13 videos.

JD Forecasting
YouTube 7 subscribers 13 videos Science & Technology
Open channel

Videos from J+D Forecasting

The most watched videos on J+D Forecasting's YouTube channel, JD Forecasting (7 subscribers). Click a video to play it here.

FC365 cloud-based pharmaceutical forecasting platform from J+D Forecasting
372 views
Performing a 'what if' scenario analysis with FC365.
124 views
J+D Spotlight on the team - Ann Wu
71 views
EpiCube : Why do we need to consider change?
51 views

More on JD Forecasting.

Investors in J+D Forecasting

J+D Forecasting has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Evaluate.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical market intelligence and forecasting solutions are provided by Evaluate.
1996evaluate.comLondon, United Kingdom
Premium access

Investor details for JD Forecasting

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of J+D Forecasting

5 people are tracked at J+D Forecasting (2 in leadership, 3 in team).

NameRoleGroup
David James
CEOLeadership
Stefano Driussi
Head Of Software EngineeringLeadership
Christine Mooney
Marketing ManagerTeam
Will J.
CRM And Digital Marketing AssistantTeam
Harry Savvides
Business Development ManagerTeam
Premium access

Complete people profiles for J+D Forecasting

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of J+D Forecasting

2 dated milestones of J+D Forecasting across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded J+D Forecasting is founded.
  2. Exit Acquired by Evaluate.

Web traffic of J+D Forecasting

Websites that share an audience with J+D Forecasting (jdforecasting.com).

Similar websites

Websites whose visitors overlap most with J+D Forecasting. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
accessinfinity.com
accessinfinity.com
100%
–#4,597,430–
thelansis.com
thelansis.com
96%
–#8,138,731–

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as J+D Forecasting (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about J+D Forecasting

Cuckoo celebrates double client win
Prolificnorth β€’ 6 years ago
Premium access

Complete news archive for JD Forecasting

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about J+D Forecasting

J+D Forecasting was founded in 2005.

J+D Forecasting is headquartered in Cheadle Hulme, United Kingdom. It is registered at Cheadle Hulme, Greater Manchester, United Kingdom.

JD Forecasting was founded in 2005 and is based in Cheadle Hulme, United Kingdom. Operations focus on the pharmaceutical sector, where forecasting servicesboth global and localare offered alongside business insights, pharmaceutical training, and software support. These services assist in strategic and operational investment decisions within the industry.

J+D Forecasting offers FC365, FC+, Custom Model Build, and Forecasting Training.

J+D Forecasting has 1 investor. Key investors include Evaluate.

J+D Forecasting operates through J&D Consulting Limited.

Yes. J+D Forecasting was acquired by Evaluate in January 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available